BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10613600)

  • 1. Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease.
    Smolewski P; Niewiadomska H; Krykowski E; Robak T
    Neoplasma; 1999; 46(4):212-8. PubMed ID: 10613600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
    Smolewski P; Niewiadomska H; Los E; Robak T
    Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin.
    Mathoulin-Portier MP; Viens P; Cowen D; Bertucci F; Houvenaeghel G; Geneix J; Puig B; Bardou VJ; Jacquemier J
    Oncol Rep; 2000; 7(3):675-80. PubMed ID: 10767389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
    Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
    J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mummified Hodgkin cell: cell death in Hodgkin's disease.
    Lorenzen J; Thiele J; Fischer R
    J Pathol; 1997 Jul; 182(3):288-98. PubMed ID: 9349231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
    Elenitoba-Johnson KS; Medeiros LJ; Khorsand J; King TC
    Am J Clin Pathol; 1996 Dec; 106(6):728-38. PubMed ID: 8980348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
    Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
    J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus.
    Tzardi M; Kouvidou C; Panayiotides I; Koutsoubi K; Stefanaki K; Giannikaki E; Darivianaki K; Zois M; Eliopoulos G; Kakolyris S; Delides G; Rontogianni D; Kanavaros P
    Anticancer Res; 1996; 16(5A):2813-9. PubMed ID: 8917390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
    Preciado MV; Cristobal E; Menarguez J; Martinez Montero JC; Diez B; De Matteo E; Grinstein S
    Pathol Res Pract; 1998; 194(1):25-31. PubMed ID: 9542744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
    Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
    Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
    Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
    Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by cyclin-dependent kinase inhibitor p21 expression.
    Ohshima K; Haraoka S; Fujiki T; Yoshioka S; Suzumiya J; Kanda M; Kikuchi M
    Pathol Int; 1999 Jun; 49(6):506-12. PubMed ID: 10469393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
    Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
    Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
    Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
    J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.